Cancer cell membrane and associated entry machinery

The cancer cell membrane and its associated entry machinery constitute a specialized interface characterized by distinct biochemical and structural alterations compared to normal cells. These changes include the externalization of phosphatidylserine, altered cholesterol distribution, and the overexpression of specific surface receptors and transporters (Birge et al., 2016, Cell Death & Differentiation). The entry machinery, which encompasses pathways like clathrin-mediated endocytosis and macropinocytosis, is often hyperactivated in malignant cells to facilitate increased nutrient uptake and the internalization of growth signals (Ha et al., 2016, Nature Reviews Cancer). This system is a primary target for therapeutic strategies such as antibody-drug conjugates (ADCs), which exploit receptor-mediated endocytosis to deliver cytotoxic agents directly into the cell. Additionally, membrane-active drugs like alkylphospholipids target the unique lipid composition of tumor membranes to induce apoptosis (Barceló-Coblijn & Fernández, 2009, Progress in Lipid Research). Despite its therapeutic potential, targeting the membrane is challenging due to the risk of off-target toxicity to healthy tissues and the inherent heterogeneity of membrane composition across different tumor types.

Other names

Tumor cell membraneNeoplastic cell surfaceCancer cell envelopeMalignant cell membrane

Induction of apoptosis through membrane lipid perturbation, inhibition of Akt signaling, and utilization of receptor-mediated endocytosis for intracellular delivery of cytotoxic payloads.